LSE creators

Number of items: 10.
None
  • Visintin, Erica, Kanavos, Panos (2021). Determinants of HTA recommendations. [Dataset]. Zenodo. https://doi.org/10.5281/zenodo.5222123
  • Nicod, Elena, Maynou, Laia, Visintin, Erica, Cairns, John (2019). Why do health technology assessment drug reimbursement recommendations differ between countries? A parallel convergent mixed methods study. Health Economics, Policy and Law, 15(3), 386-402. https://doi.org/10.1017/S1744133119000239
  • Visintin, Erica, Tinelli, Michela, Kanavos, Panos (2019). Value assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis: HTA evidence from seven OECD countries. Health Policy, 123(2), 118-129. https://doi.org/10.1016/j.healthpol.2018.08.019
  • Kanavos, Panos, Tinelli, Michela, Efthymiadou, Olina, Visintin, Erica, Grimaccia, Federico, Mossman, Jean (2016-05-25) Social impact of MS – the family burden [Other]. Asociaţia Pacienţilor cu Afecţiuni Autoimune - "Scleroza Multiplă nu trebuie să fie o povară"/Patients with Autoimmune Disorders Association - "Multiple sclerosis should not be a burden", Bucharest, Romania, ROM.
    • Public
  • Papadopoulos, Filippos, Visintin, Erica, Kyriopoulos, Ilias-Ioannis, Kanavos, Panos (2025). Why drugs fail health technology assessment: a comparative analysis of health technology assessment rejections across seven OECD countries. Health Economics, Policy and Law, 20(3), 264 - 283. https://doi.org/10.1017/S1744133125100212 picture_as_pdf
  • Kanavos, Panos, Visintin, Erica, Angelis, Aris (2024). Use of the ESMO-magnitude of clinical benefit scale to guide HTA recommendations on coverage and reimbursement for cancer medicines: a retrospective analysis. The Lancet Oncology, 25(12), 1644 - 1654. https://doi.org/10.1016/S1470-2045(24)00505-9 picture_as_pdf
  • Fontrier, Anna-Maria, Visintin, Erica, Kanavos, Panos (2022). Similarities and differences in Health Technology Assessment systems and implications for coverage decisions: evidence from 32 countries. PHARMACOECONOMICS-OPEN, 6(3), 315 - 328. https://doi.org/10.1007/s41669-021-00311-5 picture_as_pdf
  • Tinelli, Michela, Kanavos, Panos, Efthymiadou, Olina, Visintin, Erica, Grimaccia, Federico, Mossman, Jean (2017). Using IMPrESS to guide policy change in multiple sclerosis. Multiple Sclerosis Journal, 24(9). https://doi.org/10.1177/1352458517737388
  • Kanavos, Panos, Tinelli, Michela, Efthymiadou, Olina, Visintin, Erica, Grimaccia, Federico, Mossman, Jean (2016-05-17 - 2016-05-18) Towards better outcomes in multiple sclerosis by addressing policy change: the International MultiPlE Sclerosis Study (IMPrESS) [Other]. European Multiple Sclerosis Platform (EMSP) Spring Conference 2016, Oslo, Norway, NOR.
  • Kanavos, Panos, Tinelli, Michela, Efthymiadou, Olina, Visintin, Erica, Grimaccia, Federico, Mossman, Jean (2016). Towards better outcomes in multiple sclerosis by addressing policy change: the International MultiPlE Sclerosis Study (IMPrESS). London School of Economics and Political Science.